KPMA calls for more government's R&D investment

Published: 2004-10-21 07:00:00

Updated: 2004-10-21 07:00:00

The Korean government needs to focus on the development of local pharmaceutical industry through substantial R&D investment programs to nurture it as one of the nation's core growth engines, according to data released by the Korea Pharmaceutical Manufacturers Association.

The data showed that of combined sales of top 10 domestic pharmaceutical firms totaling 2.4 trillion won in 2003, their R...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.